Suivre
Matthew Molski
Matthew Molski
Adresse e-mail validée de yale.edu
Titre
Citée par
Citée par
Année
Common intermediates and kinetics, but different energetics, in the assembly of SNARE proteins
S Zorman, AA Rebane, L Ma, G Yang, MA Molski, J Coleman, F Pincet, ...
elife 3, e03348, 2014
912014
β-peptide bundles with fluorous cores
MA Molski, JL Goodman, CJ Craig, H Meng, K Kumar, A Schepartz
Journal of the American Chemical Society 132 (11), 3658-3659, 2010
582010
Tetrameric β3-peptide bundles
JL Goodman, MA Molski, J Qiu, A Schepartz
Chembiochem: a European journal of chemical biology 9 (10), 1576, 2008
362008
Remodeling a β-peptide bundle
MA Molski, JL Goodman, FC Chou, D Baker, R Das, A Schepartz
Chemical Science 4 (1), 319-324, 2013
232013
Enhancing drug development by applying LC-MS-MS for cleaning validation in manufacturing equipment
KJ Kolodsick, H Phillips, J Feng, M Molski, CA Kingsmill
Pharmaceutical technology 30 (2), 56-71, 2006
132006
Investigating the Fluorous Effect in Beta-Peptides: Towards Transmembrane Helical Bundles and the Diversification of the Octameric Beta-Bundle Core
MA Molski
Yale University, 2011
2011
journal homepage: www. elsevier. com/locate/biosystems
AJ Arenas, J Blazewicz, I Bókkon, JFY Brookfield, MB Cooper, C Cuppini, ...
Biosystems 96, 260, 2009
2009
Enhancing Drug Development by Applying LC–MS–MS for Cleaning Validation in Manufacturing Equipment
M Molski
Pharmaceutical Technology 30 (2), 0
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–8